Morgan Stanley raised Ameris Bancorp's rating, which is listed on Nasdaq and reported by MarketBeat.
3 reports, 2 independent
Updated Sat 00:00
No new developments lately
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Morgan Stanley raised Ameris Bancorp's rating, which is listed on Nasdaq and reported by MarketBeat.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Ameris Bancorp
publicly traded banking company
-
Morgan Stanley
U.S. investment bank
Related events
- MarketBeat is aggregating consensus rating data for BrightView stock, and Morgan Stanley has begun investment banking analysis on the company.
- MarketBeat is reporting consensus ratings based on reports from various competing financial institutions, including Morgan Stanley and S&P Global.
- Atea Pharmaceuticals is trading on the Nasdaq exchange, and MarketBeat and Morgan Stanley are providing research reports on the company's stock.
- MarketBeat aggregated ratings and price targets for Goldman Sachs, while Morgan Stanley and Bank of America issued new research notes and price objectives.
- Morgan Stanley downgraded enGene stock rating, which was reported by MarketBeat.